ABSTRACT

The global problem of the increase of antibiotic resistance has motivated several studies on alternative bactericidal agents. The promising materials include metal oxide nanoparticles (MONPs) due to their multi-mechanistic antibacterial action, chemical stability, and customizable physicochemical features. In this review, we critically and comparatively examined the antibacterial mechanisms of four extensively studied MONPs, namely zinc oxide (ZnO), nickel oxide (NiO), cerium oxide (CeO2), and iron oxide (Fe2O3), emphasizing the impact of particle size, morphology, surface area, crystal phase, and synthesis route on their biological activity.The four bactericidal processes addressed here, ROS generation , membrane rupture , metal ion release , and intracellular DNA damage , are comparatively analyzed across the oxide systems with emphasis on mechanistic contrasts and overlaps. The action against Gram-positive and Gram-negative bacteria is established in parallel to the demonstrated efficacy against resistant clinical infections, especially MRSA. MIC statistics reported are extensively reviewed and cytotoxicity profiles essential for biological translation are assessed for each substance.
This review provides an integrated view of mechanistic, structural and biological data to identify major knowledge gaps and to propose directions for further research, in particular on standardization of antibacterial testing protocols and the importance of strong in vivo efficacy studies.

KEYWORDS

Metal oxide nanoparticles, Antibacterial mechanisms, ZnO, NiO, CeO2, Fe2O3, Reactive oxygen species, Antimicrobial resistance, Structure activity connection

REFERENCES

1) Murray CJ, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655.
2) O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance. London: HM Government; 2016.
3) Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903–3910.
4) Slavin YN, et al. Metal nanoparticles: understanding the mechanisms behind antibacterial activity. J Nanobiotechnology. 2017;15(1):65.
5) Wang L, et al. Nanoparticles displaying microbial antigens. Nanomedicine. 2017;12(4):415–429.
6) Hemeg HA. Nanomaterials for alternative antibacterial therapy. Int J Nanomedicine. 2017;12:8211–8225.
7) Beyth N, et al. Alternative antimicrobial approach: nano-antimicrobial materials. Evid Based Complement Alternat Med. 2015;2015:246012.
8) Galdiero S, et al. Silver nanoparticles as potential antiviral agents. Molecules. 2011;16(10):8894–8918.
9) Sirelkhatim A, et al. Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-Micro Lett. 2015;7(3):219–242.
10) Elumalai K, Velmurugan S. Green synthesis, characterization and antimicrobial activities of zinc oxide nanoparticles. Appl Surf Sci. 2015;345:329–336.
11) Alpaslan E, et al. pH-Controlled cerium oxide nanoparticle inhibition of gram-positive and gram-negative bacteria growth. ACS Biomater Sci Eng. 2015;1(11):1096–1103.
12) Arakha M, et al. Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface. Sci Rep. 2015;5:14813.
13) Dizaj SM, et al. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater Sci Eng C. 2014;44:278–284.
14) Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013;65(13-14):1803–1815.
15) Azam A, et al. Antimicrobial activity of metal oxide nanoparticles against gram-positive and gram-negative bacteria. J Antibiot. 2012;65(9):465–469.
16) Jeevanandam J, et al. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol. 2018;9:1050–1074.
17) Ealias AM, Saravanakumar MP. A review on the classification, characterisation, synthesis of nanoparticles and their application. IOP Conf Ser. 2017;263:032019.
18) Niederberger M. Nonaqueous sol-gel routes to metal oxide nanoparticles. Acc Chem Res. 2007;40(9):793–800.
19) Wang X, et al. Hydrothermal synthesis of metal oxide nanomaterials for photovoltaic applications. Chem Soc Rev. 2012;41(22):7512–7535.
20) Kharissova OV, et al. The greener synthesis of nanoparticles. Trends Biotechnol. 2013;31(4):240–248.
21) Singh P, et al. Biological synthesis of nanoparticles from plants and microorganisms. Trends Biotechnol. 2016;34(7):588–599.
22) Vijayakumar S, Vaseeharan B. Antibiofilm and antivirulence properties of ZnO nanoparticles. Microb Pathog. 2018;127:1–8.
23) Thill A, et al. Cytotoxicity of CeO2 nanoparticles for Escherichia coli. Environ Sci Technol. 2006;40(19):6151–6156.
24) Iravani S. Green synthesis of metal nanoparticles using plants. Green Chem. 2011;13(10):2638–2650.
25) Zhang L, et al. Synthesis and antibacterial properties of ZnO nanoparticles. MedChemComm. 2014;5(8):1047–1053.
26) Lam SM, et al. Visible light responsive Ag/ZnO nanoparticles against bacteria. Desalin Water Treat. 2012;41(1-3):214–220.
27) Rai M, et al. Metal nanoparticles: the protective nanoshield against virus infection. Crit Rev Microbiol. 2016;42(1):46–56.
28) Chatterjee AK, et al. A broader spectrum of antibacterial activity of amorphous ZnO. Nanotechnology. 2015;26(8):085101.
29) Fujishima A, Zhang X, Tryk DA. TiO2 photocatalysis and related surface phenomena. Surf Sci Rep. 2008;63(12):515–582.
30) Dwivedi S, et al. Reactive oxygen species mediated bacterial biofilm inhibition via zinc oxide nanoparticles. RSC Adv. 2014;4(99):55985–55993.
31) Akhlaghi N, Najafpour-Darzi G. A comprehensive review on biological synthesis of nickel oxide nanoparticles. J Ind Eng Chem. 2021;103:292–305.
32) Heckert EG, et al. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials. 2008;29(18):2705–2709.
33) Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc Trans. 1894;65:899–910.
34) Goodman CM, et al. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem. 2004;15(4):897–900.
35) Seil JT, Webster TJ. Antimicrobial applications of nanotechnology: methods and literature. Int J Nanomedicine. 2012;7:2767–2781.
36) Morones JR, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16(10):2346–2353.
37) Raghupathi KR, Koodali RT, Manna AC. Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir. 2011;27(7):4020–4028.
38) Cha SH, et al. Shape-dependent biomimetic inhibition of enzyme by nanoparticles and their antibacterial activity. ACS Nano. 2015;9(9):9097–9105.
39) Xie Y, et al. Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni. Appl Environ Microbiol. 2011;77(7):2325–2331.
40) Dey A. Jewellery and nanotechnology: nickel sensitization. Asian Pac J Trop Biomed. 2012;2(4):315–318.
41) Jiang W, et al. Lanthanide nanoparticle-induced cellular toxicity. J Mater Chem. 2009;19(40):7525–7532.
42) Neilands JB. Siderophores: structure and function of microbial iron transport compounds. J Biol Chem. 1995;270(45):26723–26726.
43) Applerot G, et al. Understanding the antibacterial mechanism of CuO nanoparticles: revealing the route of induced oxidative stress. Small. 2012;8(21):3326–3337.
44) Huh AJ, Kwon YJ. ‘Nanoantibiotics’: a new paradigm for treating infectious diseases using nanomaterials. J Control Release. 2011;156(2):128–145.
45) Li M, et al. Investigating the antimicrobial activity of ZnO nanoparticles against an avirulent strain of E. coli. J Biomed Mater Res B. 2012;100(8):2097–2106.
46) Premanathan M, et al. Selective toxicity of ZnO nanoparticles toward gram-positive bacteria and cancer cells. Nanomedicine. 2011;7(2):184–192.
47) Sirelkhatim A, et al. Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-Micro Lett. 2015;7(3):219–242.
48) Fakhri A, et al. Synthesis and characterization of NiO nanoparticles by wet chemical method and evaluation of the antibacterial activity. J Appl Chem Res. 2015;9(2):22–28.
49) Ditto AJ, et al. The pharmacology of locally delivered nickel nanoparticles. J Nanopart Res. 2011;13(11):6157–6163.
50) Anantharaman A, Ling SK. Synthesis of NiO nanoparticles with enhanced antibacterial activity. Mater Today Proc. 2021;43:1662–1666.
51) Nouri A, et al. Visible light photocatalytic activity of Cu-doped NiO nanoparticles. Ceram Int. 2016;42(5):5813–5821.
52) Celardo I, et al. Pharmacological potential of cerium oxide nanoparticles. Nanoscale. 2011;3(4):1411–1420.
53) Karakoti AS, et al. Nanoceria as antioxidant: synthesis and biomedical applications. JOM. 2008;60(3):33–37.
54) Sreejivungsa K, et al. Light-controlled release of antibacterial agents from photoresponsive CeO2/Ag composites. J Photochem Photobiol A. 2016;324:10–16.
55) Mahmoudi M, et al. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2011;63(1-2):24–46.
56) Rufus A, et al. Synthesis of biogenic hematite (α-Fe2O3) nanoparticles for antibacterial and nontoxic applications. RSC Adv. 2016;6(96):94206–94217.
57) Arakha M, et al. Interfacial activity of the iron oxide nanoparticle impacts in vitro antibacterial activity. Sci Rep. 2016;6:29,628.
58) Pereira C, et al. Superparamagnetic MFe2O4 (M = Fe, Co, Mn) nanoparticles: tuning the particle size and magnetic properties. J Phys Chem C. 2012;116(30):15806–15819.
59) Barreto RA, et al. ZnO/Fe2O3 composites: preparation and evaluation of photocatalytic and antibacterial activities. Mater Lett. 2020;270:127705.
60) Nel AE, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009;8(7):543–557.
61) Jiang J, et al. Does nanoparticle activity depend upon size and crystal phase? Nanotoxicology. 2008;2(1):33–42.
62) Raghupathi KR, Koodali RT, Manna AC. Size-dependent bacterial growth inhibition. Langmuir. 2011;27(7):4020–4028.
63) Sundrarajan M, et al. Plant extract mediated biogenic synthesis of NiO nanoparticles by agathosma betulina. J Ind Eng Chem. 2017;53:224–230.
64) Stankic S, et al. Pure and multi metal oxide nanoparticles: synthesis, antibacterial and cytotoxic properties. J Nanobiotechnology. 2016;14(1):73.
65) Ong CB, Ng LY, Mohammad AW. A review of ZnO nanoparticles as solar photocatalysts: synthesis, mechanisms and applications. Renew Sustain Energy Rev. 2018;81:536–551.
66) Padmavathy N, Vijayaraghavan R. Enhanced bioactivity of ZnO nanoparticles—an antimicrobial study. Sci Technol Adv Mater. 2008;9(3):035004.
67) Lam SM, et al. Visible light responsive Ag/ZnO nanoparticles. Desalin Water Treat. 2012;41(1-3):214–220.
68) Saber O, et al. Preparation and characterization of Cu-doped ZnO nanoparticles. J Alloys Compd. 2014;615:826–832.
69) Roque-Ruiz JH, et al. Preparation and characterization of PEG-coated magnetic iron oxide nanoparticles. Mater Chem Phys. 2020;239:121998.
70) Barreto RA, et al. ZnO/Fe2O3 composites for photocatalytic and antibacterial applications. Mater Lett. 2020;270:127705.
71) Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol. 2010;2(5):a000414.
72) Tayel AA, et al. Antibacterial action of zinc oxide nanoparticles against foodborne pathogens. J Food Saf. 2011;31(2):211–218.
73) Arakha M, et al. Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface. Sci Rep. 2015;5:14813.
74) Thill A, et al. Cytotoxicity of CeO2 nanoparticles for Escherichia coli. Environ Sci Technol. 2006;40(19):6151–6156.
75) Franci G, et al. Silver nanoparticles as potential antibacterial agents. Molecules. 2015;20(5):8856–8874.
76) Boucher HW, et al. Bad bugs, no drugs: no ESKAPE! An update from the IDSA. Clin Infect Dis. 2009;48(1):1–12.
77) Ansari MA, et al. Synthesis and characterization of ZnO nanoparticles and their antimicrobial property against methicillin-resistant Staphylococcus aureus. Appl Microbiol Biotechnol. 2012;96(4):1065–1073.
78) Barreto RA, et al. ZnO/Fe2O3 nanocomposites: antibacterial activity against MRSA. Mater Lett. 2020;270:127705.
79) Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013;11(3):297–308.
80) Applerot G, et al. ZnO nanoparticle-coated surfaces inhibit biofilm formation of drug-resistant bacteria. ACS Appl Mater Interfaces. 2012;4(11):6468–6473.
81) Nel A, et al. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622–627.
82) Brunner TJ, et al. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol. 2006;40(14):4374–4381.
83) Nair S, et al. ZnO nanoparticle-coated surfaces reduce bacterial biofilm formation. ACS Nano. 2009;3(7):1815–1823.
84) Dunnick JK, et al. Characterization of biological responses of rats and mice to inhaled nickel oxide nanomaterials. Nanotoxicology. 2015;9(1):9–21.
85) Celardo I, et al. Pharmacological potential of cerium oxide nanoparticles. Nanoscale. 2011;3(4):1411–1420.
86) Laurent S, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev. 2008;108(6):2064–2110.
87) Hamdan S, et al. Nanotechnology-driven therapeutic interventions in wound healing. ACS Nano. 2017;11(11):10424–10432.
88) Mahmoudi M, Laurent S. Iron oxide nanoparticles for biomedical applications. Amsterdam: Elsevier; 2012.
89) Caputo F, et al. Measuring oxidoreductase-like activity of nanoceria. Methods Enzymol. 2017;590:1–28.
90) He X, Deng H, Hwang HM. The current application of nanotechnology in food and agriculture. J Food Drug Anal. 2019;27(1):1–21.
91) Bumbudsanpharoke N, Ko S. Nano-food packaging: an overview of market, migration research, and safety regulations. J Food Sci. 2015;80(5):R910–R923.
92) Gupta G, et al. Solar photocatalytic disinfection of water. Adv Mater Lett. 2014;5(9):501–508.
93) Bousiakou LG, et al. CeO2 nanoparticles for the removal of antibiotics from hospital wastewater. Sci Total Environ. 2019;657:1144–1153.
94) Keller AA, et al. Global life cycle releases of engineered nanomaterials. J Nanopart Res. 2013;15(6):1692.
95) CLSI. M07-A10: Methods for dilution antimicrobial susceptibility tests for bacteria. Wayne, PA: CLSI; 2015.
96) Nel AE, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009;8(7):543–557.
97) Ahamed M, et al. Synthesis and bioactivity of nickel oxide nanoparticles against human lung cancer cells. J Hazard Mater. 2013;261:188–195.
98) WHO. Global priority list of antibiotic-resistant bacteria to guide research. Geneva: WHO; 2017.
99) Nowack B, Bucheli TD. Occurrence, behavior and effects of nanoparticles in the environment. Environ Pollut. 2007;150(1):5–22.

Cite this article 

Kazem, G. A. (2026). Comparative Antibacterial Mechanisms of Metal Oxide Nanoparticles (Zno, Nio, Ceo2, And Fe2O3): A Critical Review of Structure-Activity Relationships and Emerging Applications. INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH, 5(7), 699-711. https://doi.org/10.58806/ijhmr.2026.v5i7n17